News Releases

ITUS Subsidiary Anixa Diagnostics Corporation Appoints Dr. Michael Shepard to Its Scientific Advisory Board

December 7, 2015

ITUS Subsidiary Anixa Diagnostics Corporation Announces Initial Cancer Biomarker Results

October 5, 2015

ITUS Subsidiary Anixa Diagnostics Enters Into Collaborative Research Agreement With The Wistar Institute, a Leading Cancer Research Institute

July 14, 2015

ITUS Announces Uplisting to NASDAQ

July 9, 2015

ITUS Announces Reverse Stock Split With the Intention to List Shares on NASDAQ

June 25, 2015

ITUS Announces Formation of Cancer Diagnostics Subsidiary

June 23, 2015

ITUS Releases Operating Results for Fiscal 2014

January 29, 2015

Latest News & Events

Mar 4, 2021

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy

Read More...

Feb 25, 2021

Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference

Read More...

Feb 16, 2021

Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates

Read More...